Frequently Asked Questions About UNVO.TA

What does Univo Pharmaceuticals Ltd do?

Univo Pharmaceuticals Ltd (UNVO.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is UNVO.TA's market cap?

Univo Pharmaceuticals Ltd (UNVO.TA) has a market capitalization of approximately $28.73 billion, as of December 15, 2022, based on the most recent share price and shares outstanding.

Does UNVO.TA pay a dividend?

No — Univo Pharmaceuticals Ltd (UNVO.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is UNVO.TA profitable?

Univo Pharmaceuticals Ltd (UNVO.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

UNVO.TA (Univo Pharmaceuticals Ltd) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

UNVO.TA

Univo Pharmaceuticals Ltd

TLV·Biotechnology · Healthcare

ILA 9.40ILA 0.10+1.08%

Market capILA 28.73B·Dec 15 3:24 PM UTC

Price Chart

ILA 9.40+ILA 0.10 (+1.08%)today

+244.32%CAGR +28.06%

Select date range

FromTo

Nov 9, 2010Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

UNVO.TA does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how UNVO.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for UNVO.TA and 80,000+ other tickers.

About Univo Pharmaceuticals Ltd

Based in Ashkelon, Israel, Univo Pharmaceuticals Ltd, founded in 1993, focuses on the creation, production, and distribution of medical cannabis items. The company adopted its present name, Univo Pharmaceuticals Ltd, in September 2018, having previously been known as Di-Pharm Ltd.

CEO: Golan Bitton
Sector: Healthcare
Industry: Biotechnology
Exchange: TLV
Employees: 76
Website: www.unv-medicine.com

Peers

ENvizion Medical Ltd.

Cap

ILA 13.9B

CSURE.TA

Cannassure Therapeutics Ltd

Cap

ILA 2.2B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About UNVO.TA

What does Univo Pharmaceuticals Ltd do?: Univo Pharmaceuticals Ltd (UNVO.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is UNVO.TA's market cap?: Univo Pharmaceuticals Ltd (UNVO.TA) has a market capitalization of approximately $28.73 billion, as of December 15, 2022, based on the most recent share price and shares outstanding.
Does UNVO.TA pay a dividend?: No — Univo Pharmaceuticals Ltd (UNVO.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is UNVO.TA profitable?: Univo Pharmaceuticals Ltd (UNVO.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.